Ohlbe ★★★ France, 2020-04-29 01:01 (1430 d 10:13 ago) Posting: # 21358 Views: 2,891 |
|
Dear all, The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence. — Regards Ohlbe |